ACTA1 and pulmonary fibrosis: Results showed that mice treated with AAV9‐shSema3E exhibited lower protein and mRNA levels of Fibronectin, Col1a1, and α‐SMA expression following BLM‐induced pulmonary fibrosis compared to AAV9‐NC mice (Figure 6D,E).